Platelet aggregation measured by single-platelet counting and using PFA-100 devices

References

• Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–929. doi:10.1038/194927b0
   PubMed Web of Science ®Google Scholar
• Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods. 1980;3:135–158. doi:10.1016/0160-5402(80)90024-8
   PubMedGoogle Scholar
• Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006;96:781–788. doi:10.1160/TH06-05-0242
   PubMed Web of Science ®Google Scholar
• Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, Von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849–856. doi:10.1016/j.jacc.2008.11.030
   PubMed Web of Science ®Google Scholar
• Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function ana lyzer–PFA-100. Semin Thromb Hemost. 1995;21:106–112. doi:10.1055/s-0032-1313612
   PubMed Web of Science ®Google Scholar
• Kratzer MA, Born GV. Simulation of primary haemostasis in vitro. Haemostasis. 1985;15:357–362.
   PubMedGoogle Scholar
• Favaloro EJ. Clinical utility of closure times using the platelet function analyzer-100/200. Am J Hematol. 2017;92:398–404. doi:10.1002/ajh.24620
   PubMed Web of Science ®Google Scholar
• Harrison P, Robinson MS, Mackie IJ, Joseph J, McDonald SJ, Liesner R, Savidge GF, Pasi J, Machin SJ. Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis. 1999;10:25–31. doi:10.1097/00001721-199901000-00004
   PubMed Web of Science ®Google Scholar
• Harrison P, Robinson M, Liesner R, Khair K, Cohen H, Mackie I, Machin S. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol. 2002;24:225–232. doi:10.1046/j.1365-2257.2002.00451.x
   PubMedGoogle Scholar
• Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood. 1998;91:1325–1331.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Lecchi A, Agati B, Lombardi R, Zighetti ML. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res. 1999;96:213–217. doi:10.1016/S0049-3848(99)00102-4
   PubMed Web of Science ®Google Scholar
• Quiroga T, Goycoolea M, Munoz B, Morales M, Aranda E, Panes O, Pereira J, Mezzano D. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost. 2004;2:892–898. doi:10.1111/j.1538-7836.2004.00693.x
   PubMed Web of Science ®Google Scholar
• Sladky JL, Klima J, Grooms L, Kerlin BA, O’Brien SH. The PFA-100® does not predict delta-granule platelet storage pool deficiencies. Haemophilia. 2012;18:626–629. doi:10.1111/j.1365-2516.2011.02733.x
   PubMed Web of Science ®Google Scholar
• Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost. 2003;1:1628–1636. doi:10.1046/j.1538-7836.2003.00266.x
   PubMed Web of Science ®Google Scholar
• Scavone M, Germanovich K, Femia EA, Cattaneo M. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Res. 2014;133:254–256. doi:10.1016/j.thromres.2013.10.032
   PubMed Web of Science ®Google Scholar
• Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost. 2006;4:312–319. doi:10.1111/j.1538-7836.2006.01771.x
   PubMed Web of Science ®Google Scholar
• Carcao MD, Blanchette VS, Stephens D, He L, Wakefield CD, Butchart S, Christie DJ, Rand ML. Assessment of thrombocytopenic disorders using the platelet function analyzer (PFA-100). Br J Haematol. 2002;117:961–964.
   PubMed Web of Science ®Google Scholar
• Kuiper GJAJM, Houben R, Wetzels RJH, Verhezen PWM, Oerle RV, Ten Cate H, Henskens YMC, Lancé MD. The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function. Platelets. 2017;28:668–675. doi:10.1080/09537104.2016.1257782
   PubMed Web of Science ®Google Scholar
• Heilmann EJ, Kundu SK, Sio R, Garcia C, Gomez R, Christie DJ. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA- 100 system. Thromb Res. 1997;87:159–164. doi:10.1016/S0049-3848(97)00115-1
   PubMed Web of Science ®Google Scholar
• Gresele P, Harrison P, Gachet C, Hayward C, Kenny D, Mezzano D, Mumford A, Nugent D, Nurden A, Cattaneo M. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2014;13:314–322. doi:10.1111/jth.12792
   Web of Science ®Google Scholar
• Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward CP, Kenny D, Mezzano D, Mumford AD, Nugent D, et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost. 2014;12:1562–1569. doi:10.1111/jth.12513
   PubMed Web of Science ®Google Scholar
• Hézard N, Metz D, Nazeyrollas P, Droullé C, Potron G, Nguyen P. PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty? Thromb Res. 2002;108:43–47.
   PubMed Web of Science ®Google Scholar
• Sambola A, Heras M, Escolar G, Lozano M, Pino M, Martorell T, Torra M, Sanz G. The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin. Platelets. 2004;15:439–446.
   PubMed Web of Science ®Google Scholar
• Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell PM. Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke. 2005;36:1001–1005. doi:10.1161/01.STR.0000162719.11058.bd
   PubMed Web of Science ®Google Scholar
• Linnemann B, Schwonberg J, Rechner AR, Mani H, Lindhoff-Last E. Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y. Ann Hematol. 2010;89:597–605. doi:10.1007/s00277-009-0881-9
   PubMed Web of Science ®Google Scholar
• Edwards A, Jakubowski JA, Rechner AR, Sugidachi A, Harrison P. Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant. Platelets. 2012;23:106–115. doi:10.3109/09537104.2011.601361
   PubMed Web of Science ®Google Scholar
• Koessler J, Kobsar AL, Rajkovic MS, Schafer A, Flierl U, Pfoertsch S, Bauersachs J, Steigerwald U, Rechner AR, Walter U. The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition. Platelets. 2011;22:20–27. doi:10.3109/09537104.2010.514967
   PubMed Web of Science ®Google Scholar
• Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JR. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost. 1982;48:327–329.
   PubMed Web of Science ®Google Scholar
• Campbell J, Ridgway H, Carville D. Plateletworks: a novel point of care platelet function screen. Mol Diagn Ther. 2008;12:253–258.
   PubMed Web of Science ®Google Scholar
• White MM, Krishnan R, Kueter TJ, Jacoski MV, Jennings LK. The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIB-IIIa antagonists. J Thromb Thrombolysis. 2004;18:163–169. doi:10.1007/s11239-005-0341-x
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Kleibeuker M, Postma S, Bouman HJ, Elsenberg EH, Ten Berg JM, Hackeng CM. A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int J Cardiol. 2010;140:123–126. doi:10.1016/j.ijcard.2008.10.046
   PubMed Web of Science ®Google Scholar
• Lennon MJ, Gibbs NM, Weightman WM, McGuire D, Michalopoulos N. A comparison of Plateletworks and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004;18:136–140.
   PubMed Web of Science ®Google Scholar
• Lordkipanidzé M, Pharand C, Schampaert E, Palisaitis DA, Diodati JG. Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry. Thromb Res. 2009;124:418–422. doi:10.1016/j.thromres.2009.02.002
   PubMed Web of Science ®Google Scholar
• Shaffer KE, Pearman DT, Galen RS, Carville DG. A rapid platelet function assay used to regulate platelet transfusion prophylaxis following cardiopulmonary bypass surgery. J Extra Corpor Technol. 2004;36:145–148.
   PubMedGoogle Scholar
• Konstantopoulos K, Wu KK, Udden MM, Bañez EI, Shattil SJ, Hellums JD. Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology. 1995;32:73–93.
   PubMed Web of Science ®Google Scholar
• Turner NA, Moake JL, McIntire LV. Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. Blood. 2001;98:3340–3345.
   PubMed Web of Science ®Google Scholar
• Fox SC, Sasae R, Janson S, May JA, Heptinstall S. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets. 2004;15:85–93. doi:10.1080/09537100310001645979
   PubMed Web of Science ®Google Scholar
• Fox SC, May JA, Johnson A, Hermann D, Strieter D, Hartman D, Heptinstall S. Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12 antagonist both in-vitro and ex-vivo in human volunteers. Platelets. 2013;24:392–400. doi:10.3109/09537104.2012.704648
   PubMed Web of Science ®Google Scholar
• Xavier RG, White AE, Fox SC, Wilcox RG, Heptinstall S. Enhanced platelet aggregation and activation under conditions of hypothermia. Thromb Haemost. 2007;98:1266–1275.
   PubMed Web of Science ®Google Scholar
• Iyú D, Glenn JR, White AE, Fox SC, Dovlatova N, Heptinstall S. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP. Platelets. 2011;22:504–515. doi:10.3109/09537104.2011.576284
   PubMed Web of Science ®Google Scholar
• Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol. 1984;37:874–878.
   PubMed Web of Science ®Google Scholar
• De Cuyper IM, Meinders M, van de Vijver E, De Korte D, Porcelijn L, De Haas M, Eble JA, Seeger K, Rutella S, Pagliara D, et al. A novel flow cytometry- based platelet aggregation assay. Blood. 2013;121:e70–e80. doi:10.1182/blood-2012-06-437723
   PubMed Web of Science ®Google Scholar
• Vinholt PJ, Frederiksen H, Hvas A-M, Sprogøe U, Nielsen C. Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach. J Thromb Haemost. 2017;15:1191–1202. doi:10.1111/jth.13632
   PubMed Web of Science ®Google Scholar
• Chan MV, Armstrong PC, Papalia F, Kirkby NS, Warner TD. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets. 2011;22:485–494. doi:10.3109/09537104.2011.592958
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M, Dovlatova N, Lowe G, Watson SP, Fox SC Development of a novel high throughput 96 well plate-based whole blood assay for investigation of platelet function in healthy volunteers and patients with clinically diagnosed bleeding disorders. Presented at XXIV Congress of the International Society of Thrombosis and Haemostasis 2013. Amsterdam, ref. PB 3.22–23.
   Google Scholar
• Algahtani M, Dovlatova N, May J, Heptinstall S, Fox S. Immediate fixation of treated blood samples enables flow cytometric measurement of platelet aggregation and platelet-leucocyte conjugate formation in small volumes of blood. Int J Lab Hematol. 2014;36(Suppl 1):61–62.
   Google Scholar
• Armstrong PC, Kirkby NS, Chan MV, Finsterbusch M, Hogg N, Nourshargh S, Warner TD. Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction. Blood. 2015;126:e11–8. doi:10.1182/blood-2015-01-621656
   PubMed Web of Science ®Google Scholar
• Fox SC, May JA, Shah A, Neubert U, Heptinstall S. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets. 2009;20:250–259. doi:10.1080/09537100902912451
   PubMed Web of Science ®Google Scholar
• Dovlatova N, Lordkipanidzé M, Lowe GC, Dawood B, May J, Heptinstall S, Watson SP. Fox SC; UK GAPP Study Group. Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders. J Thromb Haemost. 2014;12:660–665. doi:10.1111/jth.12555
   PubMed Web of Science ®Google Scholar
• Dovlatova N, May JA, Fox SC. Remote platelet function testing––significant progress towards widespread testing in clinical practice. Platelets. 2015;26:399–401. doi:10.3109/09537104.2015.1043880
   PubMed Web of Science ®Google Scholar